Project-002
Project-002
批准号:
10794919
负责人:
Richard Thomas Wyatt
金额:
$50.33万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-02-04 至 2026-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Circulating (tier 2) HIV-1 variants are highly resistant to antibody-mediated neutralization, making broadly
effective vaccine design a major challenge. Encouragingly, work in our previous HIVRAD program
demonstrated that Ab responses capable of cross-neutralizing multiple heterologous tier 2 viruses were
elicited by targeted N-glycan deletion priming and heterologous glycan restorative Env trimer-liposome
boosting. The isolation of two monoclonal antibodies with broadly neutralizing activity from these studies
and high-resolution structures in complex with native-like trimers revealed that one mAb targeted the
conserved CD4 binding site (CD4bs) and the other targeted the gp41:gp120 interface region,
substantiated this result. In the current application, we will build on these efforts by evaluating responses
elicited by well-ordered, novel, trimer-based immunogens inoculated into Indian origin rhesus macaques.
In addition to the use pf protein-based trimers, we will test trimer platforms based on administration of
mRNA lipid nanoparticles as described in Project 1.
In Project 2, we will characterize B cell responses elicited by vaccine regimens evaluated in Indian origin
rhesus macaques in Core B by rapid, high-throughput monoclonal antibody (mAb) isolation to
define the targeted epitopes and guide both the choice of boosting immunogens and, if needed, trimer
redesign by eliminating or masking unwanted non-neutralizing immunodominant responses for
subsequent immunization studies. We will interact with the investigators in Core C, who also will generate
information about immunodominant Ab responses through their negative stain electron microscopy
(nsEM)-based method for evaluation of vaccine-induced serum responses. Using the Env-specific mAbs,
we will further determine how Env-specific antibody lineages evolve over time using Next Generation
Sequencing (NGS) and IgDiscover, a computational tool optimized for use in rhesus macaques. We will
generate individualized databases of macaque germline VDJ alleles for precise gene assignments, which
is necessary for correct conclusions about Ab affinity maturation and SHM levels. We will further use
the IgDiscover results and the new haplotype module to investigate if certain alleles, or combinations of
alleles, predispose to elicitation of neutralizing Ab responses in either adult of juvenile macaques. We
will investigate the level of expansion of neutralizing and non-neutralizing Ab lineages over time and
ask if vaccine-induced neutralizing Ab lineages persist in long-lived immune compartments such
as memory B cells and plasma cells, which are critical for the long-term protective effects of vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates
-
批准号:10339439
-
项目类别:
-
资助金额:$342.0万
-
财政年份:2021
-
负责人:Richard Thomas Wyatt
-
依托单位:
Core-002
-
批准号:10794904
-
项目类别:
-
资助金额:$113.05万
-
财政年份:2021
-
负责人:Richard Thomas Wyatt
-
依托单位:
Project 1
-
批准号:10339443
-
项目类别:
-
资助金额:$115.59万
-
财政年份:2021
-
负责人:Richard Thomas Wyatt
-
依托单位:
Admin Core
-
批准号:10339440
-
项目类别:
-
资助金额:$21.4万
-
财政年份:2021
-
负责人:Richard Thomas Wyatt
-
依托单位:
Core-001
-
批准号:10782243
-
项目类别:
-
资助金额:$139.64万
-
财政年份:2021
-
负责人:Richard Thomas Wyatt
-
依托单位:
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates
-
批准号:10549838
-
项目类别:
-
资助金额:$340.27万
-
财政年份:2021
-
负责人:Richard Thomas Wyatt
-
依托单位:
Admin-Core-001
-
批准号:10794918
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2021
-
负责人:Richard Thomas Wyatt
-
依托单位:
N-glycan baiting to target the highly effective HIV Env shield
-
批准号:10388295
-
项目类别:
-
资助金额:$96.18万
-
财政年份:2019
-
负责人:Richard Thomas Wyatt
-
依托单位:
N-glycan baiting to target the highly effective HIV Env shield
-
批准号:9754560
-
项目类别:
-
资助金额:$67.15万
-
财政年份:2019
-
负责人:Richard Thomas Wyatt
-
依托单位:
N-glycan baiting to target the highly effective HIV Env shield
-
批准号:10333202
-
项目类别:
-
资助金额:$96.18万
-
财政年份:2019
-
负责人:Richard Thomas Wyatt
-
依托单位:
N-glycan baiting to target the highly effective HIV Env shield
-
批准号:9918868
-
项目类别:
-
资助金额:$67.15万
-
财政年份:2019
-
负责人:Richard Thomas Wyatt
-
依托单位:
High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design
-
批准号:8680621
-
项目类别:
-
资助金额:$265.98万
-
财政年份:2014
-
负责人:Richard Thomas Wyatt
-
依托单位:
Structure and Immunogenicity of HIV-1 gp41 Membrane Prox
-
批准号:7299877
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard Thomas Wyatt
-
依托单位:
Immmunogenicity and Structure of trimeric HIV-1 gp120 gl
-
批准号:7184287
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard Thomas Wyatt
-
依托单位:
HIV-1 Solid Phase Proteoliposome
-
批准号:7184256
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard Thomas Wyatt
-
依托单位:
Biophysics /Structure /Immunogenicity of HIV-1Glycoprote
-
批准号:7189318
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard Thomas Wyatt
-
依托单位:
Production And Characterization Of HIV-1 Solid Phase Proteoliposomes
-
批准号:7732748
-
项目类别:
-
资助金额:$41.47万
-
财政年份:--
-
负责人:Richard Thomas Wyatt
-
依托单位:
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera
-
批准号:7592436
-
项目类别:
-
资助金额:$19.16万
-
财政年份:--
-
负责人:Richard Thomas Wyatt
-
依托单位:
Administrative Core
-
批准号:8829138
-
项目类别:
-
资助金额:$10.27万
-
财政年份:--
-
负责人:Richard Thomas Wyatt
-
依托单位:
Administrative Core
-
批准号:8680626
-
项目类别:
-
资助金额:$11.26万
-
财政年份:--
-
负责人:Richard Thomas Wyatt
-
依托单位:
国内基金
海外基金
登录
查看更多内容
锌粉(002)晶面定向调控及其负极性能强化机理研究
-
批准号:2025JJ70625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曹鹏辉
-
依托单位:
新型核素偶联药载体JBN002-DOTA的开发及其在肿瘤诊疗中的应用
-
批准号:82373174
-
项目类别:面上项目
-
资助金额:60万元
-
批准年份:2023
-
负责人:杨杰
-
依托单位:
tiRNA-Val-CAC-002介导ITGB3/PI3K/Akt调控FB自噬促进OSF发生机制研究
-
批准号:2023JJ30946
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:吴颖芳
-
依托单位:
双胍新衍生物SMK-002阻断PKM2入核下调脂质合成抑制EMT阻止膀胱癌转移的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:杨小平
-
依托单位:
tiRNA-Gly-GCC-002 调控FKBP5 在狼疮性肾炎肾小管上皮细胞损伤中的作用及机制研究
-
批准号:LY22H050004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈朝生
-
依托单位:
关键挥发性有机物介导根际促生菌NRCB002定殖的根际生物学机制
-
批准号:32172673
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:高南
-
依托单位:
(002)取向石墨化碳材料的制备及其储钾性能
-
批准号:22075268
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:林宁
-
依托单位:
外泌体lncRNAuc002ktr.3在肺鳞癌顺铂耐药中的作用及其作为新型耐药标志物的临床价值
-
批准号:81972006
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:王保龙
-
依托单位:
宿主LncRNAs LNC_002与Linc00152调控肠道病原菌感染炎症反应的分子机制研究
-
批准号:81902027
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:王建伟
-
依托单位:
RELA/ LncRNA-uc002jit.1/PARP1形成环路调节DNA修复对DNA损伤药物清除白血病干细胞的影响
-
批准号:81872898
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:吴丽贤
-
依托单位: